Take the Quiz
Clinical Reference · Updated 2026-05-25

FLOW Trial Results

Released: Last reviewed:

FLOW (NEJM 2024, PMID 38785189): 24% reduction in major kidney/CV events in T2D + CKD over median 3.4 years.

Clinical referencePubMed-linkedUpdated 2026-05-25
Researched By
Dr. Parmis
Medical Researcher · Western University of Health Sciences
Medically Reviewed By
Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)
Last medically reviewed: October 15, 2026 · This page is informational and does not constitute medical advice.

Overview

FLOW (NEJM 2024, PMID 38785189): 24% reduction in major kidney/CV events in T2D + CKD over median 3.4 years.

PubMed citations

Related clinical pages